A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA ...

Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...

Dendritic cells (DCs) serve as pivotal sentinels of the immune system, bridging innate and adaptive responses by processing and presenting antigens to T cells. Their inherent versatility enables them ...

LMU researchers have shown that a particular type of immune cell acts more flexibly than previously thought - with potential for new therapeutic approaches. As part of the innate immune system, ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

In a breakthrough that could potentially rewrite the prevention and treatment of cancer, scientists have discovered how ...

Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.

BPDCN is an aggressive type of blood cancer that originates from plasmacytoid dendritic cells (pDCs), a component of the immune system that produces type 1 interferon cytokines. These cytokines help ...

New research shows Pfizer and Moderna mRNA vaccines enhance survival for lung and melanoma cancer patients on immunotherapy, ...

The intestinal immune system can usually recognize friend from foe. But for approximately 30 million Americans with food allergies—including four million children—immune cells mistakenly identify food ...